title: Antiemetic effects of metoclopramide (M) continuous infusion (CI): safety, efficacy, patient preference, and cost reduction.
authors: Wilshire Oncology Medical Group, Los Angeles, California.
authors: C A
authors: CA
authors: Presant
authors: C
authors: C
authors: Wiseman
authors: K
authors: K
authors: Gala
authors: P
authors: P
authors: Kennedy
authors: A
authors: A
authors: Bouzaglou
authors: D
authors: D
authors: Blayney
authors: J
authors: J
authors: Schindler
authors: M
authors: M
authors: Rigas
authors: J
authors: J
authors: Melville
authors: J
authors: J
authors: Dolan
mesh_terms: D002945:Cisplatin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008787:Metoclopramide / Q000627:therapeutic use*; D009325:Nausea / Q000139:chemically induced* / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D014839:Vomiting / Q000139:chemically induced* / Q000188:drug therapy
chemical_list: D008787:Metoclopramide; D002945:Cisplatin